<?xml version="1.0" encoding="utf-8" ?>
<feed xmlns="http://www.w3.org/2005/Atom">
<title>Kiyara - Latest News</title>
<link href="https://news.prfree.org/rss/kiyara/latest.xml"></link>
<updated>2026-07-20T12:49:33+00:00</updated>
<id>urn:uuid:1585b998-6840-91ce-990c-974480e89975</id>
<entry>
<title>Chronic Obstructive Pulmonary Disease (COPD) – Pipeline Review, H1 2020</title>
<link href="https://news.prfree.org/@kiyara/chronic-obstructive-pulmonary-disease-copd-pipeline-review-h1-2020-y7m8enybake8"></link>
<id>urn:uuid:3315dd6b-f88e-a39a-715e-eb50acdc904e</id>
<summary type="html"><![CDATA[latest Pharmaceutical and Healthcare disease pipeline guide Chronic Obstructive Pulmonary Disease – Pipeline Review, H1 2020, provides an overview of the Chronic Obstructive Pulmonary Disease (Respiratory) pipeline landscape.]]></summary>
<updated>2020-05-15T13:08:01+00:00</updated>
</entry>
<entry>
<title>Idiopathic Pulmonary Fibrosis – Pipeline Review, H1 2020</title>
<link href="https://news.prfree.org/@kiyara/idiopathic-pulmonary-fibrosis-pipeline-review-h1-2020-3rmwrj36xkn4"></link>
<id>urn:uuid:cf11cd8f-934f-7c15-2f96-3a4f487522b0</id>
<summary type="html"><![CDATA[Latest Pharmaceutical and Healthcare disease pipeline guide Idiopathic Pulmonary Fibrosis – Pipeline Review, H1 2020, provides an overview of the Idiopathic Pulmonary Fibrosis (Respiratory) pipeline landscape.]]></summary>
<updated>2020-05-15T13:05:25+00:00</updated>
</entry>
<entry>
<title>Atherosclerosis – Pipeline Review, H1 2020</title>
<link href="https://news.prfree.org/@kiyara/atherosclerosis-pipeline-review-h1-2020-6rmywn8qpmb4"></link>
<id>urn:uuid:ff51a9d1-835b-5688-2fd9-83fd29b42221</id>
<summary type="html"><![CDATA[Latest Pharmaceutical and Healthcare disease pipeline guide Atherosclerosis – Pipeline Review, H1 2020, provides an overview of the Atherosclerosis (Cardiovascular) pipeline landscape.]]></summary>
<updated>2020-05-15T13:03:26+00:00</updated>
</entry>
<entry>
<title>Organophosphate and Carbamate Poisoning – Pipeline Review, H1 2020</title>
<link href="https://news.prfree.org/@kiyara/organophosphate-and-carbamate-poisoning-pipeline-review-h1-2020-b7kxrn4e6kry"></link>
<id>urn:uuid:a2a14142-bdcd-2c2c-2fe1-904cc9c13a40</id>
<summary type="html"><![CDATA[Latest Pharmaceutical and Healthcare disease pipeline guide Organophosphate and Carbamate Poisoning – Pipeline Review, H1 2020, provides an overview of the Organophosphate and Carbamate Poisoning (Other Diseases) pipeline landscape.]]></summary>
<updated>2020-05-15T13:01:09+00:00</updated>
</entry>
<entry>
<title>Hypertrophic Cardiomyopathy – Pipeline Review, H1 2020</title>
<link href="https://news.prfree.org/@kiyara/hypertrophic-cardiomyopathy-pipeline-review-h1-2020-ypm4axb4qk85"></link>
<id>urn:uuid:b90b0fdb-4121-4d94-b6d6-444431854e83</id>
<summary type="html"><![CDATA[Latest Pharmaceutical and Healthcare disease pipeline guide Hypertrophic Cardiomyopathy – Pipeline Review, H1 2020, provides an overview of the Hypertrophic Cardiomyopathy (Cardiovascular) pipeline landscape.]]></summary>
<updated>2020-05-15T12:59:05+00:00</updated>
</entry>
<entry>
<title>Peripheral Arterial Disease / Peripheral Vascular Disease  – Pipeline Review, H1 2020</title>
<link href="https://news.prfree.org/@kiyara/peripheral-arterial-disease-peripheral-vascular-disease-pipeline-review-h1-2020-eqmjbnn5ymr6"></link>
<id>urn:uuid:280b26d3-2126-e1d5-73ea-33ff4bd8afc5</id>
<summary type="html"><![CDATA[Latest Pharmaceutical and Healthcare disease pipeline guide Peripheral Arterial Disease Peripheral Vascular Disease – Pipeline Review, H1 2020]]></summary>
<updated>2020-05-14T13:18:38+00:00</updated>
</entry>
<entry>
<title>Behcet Disease – Pipeline Review, H1 2020</title>
<link href="https://news.prfree.org/@kiyara/behcet-disease-pipeline-review-h1-2020-6rm5pbbqwkw4"></link>
<id>urn:uuid:7fb5bbdc-4695-2842-a7dc-89165b41a344</id>
<summary type="html"><![CDATA[Latest Pharmaceutical and Healthcare disease pipeline guide Behcet Disease – Pipeline Review, H1 2020, provides an overview of the Behcet Disease (Cardiovascular) pipeline landscape.]]></summary>
<updated>2020-05-14T13:10:56+00:00</updated>
</entry>
<entry>
<title>Ventricular Tachycardia – Pipeline Review, H1 2020</title>
<link href="https://news.prfree.org/@kiyara/ventricular-tachycardia-pipeline-review-h1-2020-3rm6qbbj8keq"></link>
<id>urn:uuid:df5bc851-f837-6047-89c6-71a38fd808c7</id>
<summary type="html"><![CDATA[Latest Pharmaceutical and Healthcare disease pipeline guide Ventricular Tachycardia – Pipeline Review, H1 2020, provides an overview of the Ventricular Tachycardia (Cardiovascular) pipeline landscape.]]></summary>
<updated>2020-05-14T13:07:50+00:00</updated>
</entry>
<entry>
<title>Vaso-Occlusive Crisis Associated With Sickle Cell Disease – Pipeline Review, H1 2020</title>
<link href="https://news.prfree.org/@kiyara/vaso-occlusive-crisis-associated-with-sickle-cell-disease-pipeline-review-h1-2020-3rmwrjj3ekn4"></link>
<id>urn:uuid:a97e984e-8902-8832-6903-89471a67986e</id>
<summary type="html"><![CDATA[Latest Pharmaceutical and Healthcare disease pipeline guide Vaso-Occlusive Crisis Associated With Sickle Cell Disease – Pipeline Review, H1 2020]]></summary>
<updated>2020-05-14T13:05:55+00:00</updated>
</entry>
<entry>
<title>Parkinson’s Disease – Pipeline Review, H1 2020</title>
<link href="https://news.prfree.org/@kiyara/parkinson-s-disease-pipeline-review-h1-2020-63mb633jxmb7"></link>
<id>urn:uuid:2d006728-a175-34cd-a54f-6a6632485317</id>
<summary type="html"><![CDATA[Latest Pharmaceutical and Healthcare disease pipeline guide Parkinson’s Disease – Pipeline Review, H1 2020, provides an overview of the Parkinson’s Disease (Central Nervous System) pipeline landscape.]]></summary>
<updated>2020-05-14T13:04:02+00:00</updated>
</entry>
<entry>
<title>CMO Scorecard: Outsourcing of NDA Approvals and CMO Performance – 2020 Edition</title>
<link href="https://news.prfree.org/@kiyara/cmo-scorecard-outsourcing-of-nda-approvals-and-cmo-performance-2020-edition-qak74ya34my3"></link>
<id>urn:uuid:bc2e2663-5e19-0048-47d1-93c0436cbadb</id>
<summary type="html"><![CDATA[This report is the 10th edition of our long running analysis of the CMO Industry, using NDA approvals as the primary indicator of performance.]]></summary>
<updated>2020-05-13T12:17:14+00:00</updated>
</entry>
<entry>
<title>Direct to Customer in Insurance – Thematic Research</title>
<link href="https://news.prfree.org/@kiyara/direct-to-customer-in-insurance-thematic-research-6rmyb3reakb4"></link>
<id>urn:uuid:a20aaadb-a745-d28a-1da9-a4ce17349f64</id>
<summary type="html"><![CDATA[As digitization continues to shape customers’ attitudes and purchasing behaviors, insurers are being forced to rethink their]]></summary>
<updated>2020-05-13T12:15:26+00:00</updated>
</entry>
<entry>
<title>Ring Inc. – Tech Innovator Profile</title>
<link href="https://news.prfree.org/@kiyara/ring-inc-tech-innovator-profile-eqmj7yqwdkr6"></link>
<id>urn:uuid:82cfa562-26c8-8b93-101a-12d869aa7ce2</id>
<summary type="html"><![CDATA[Ring Inc. (Ring) is a smart home solutions company that offers home security products. The company manufactures connected devices for homes and helps secure even neighborhoods.]]></summary>
<updated>2020-05-13T12:13:49+00:00</updated>
</entry>
<entry>
<title>23andMe, Inc. – Tech Innovator Profile</title>
<link href="https://news.prfree.org/@kiyara/23andme-inc-tech-innovator-profile-eqm36wxebkdy"></link>
<id>urn:uuid:95869dd0-73df-d99f-6f15-9b953f8cb702</id>
<summary type="html"><![CDATA[23andMe, Inc. (23andMe) is a personal genomics and biotechnology company that leverages machine learning (ML) technology to provide DNA analysis services.]]></summary>
<updated>2020-05-13T12:11:39+00:00</updated>
</entry>
<entry>
<title>Ascenda: Competitor Profile</title>
<link href="https://news.prfree.org/@kiyara/ascenda-competitor-profile-6rm583yeykw4"></link>
<id>urn:uuid:b82cce3d-6d2f-c57a-008b-c044feaebe66</id>
<summary type="html"><![CDATA[Ascenda is a global provider of loyalty solutions, offering reward propositions for major financial services providers and travel brands worldwide.]]></summary>
<updated>2020-05-13T12:09:57+00:00</updated>
</entry>
<entry>
<title>Age-Related Macular Degeneration: Global Drug Forecast and Market Analysis to 2028</title>
<link href="https://news.prfree.org/@kiyara/age-related-macular-degeneration-global-drug-forecast-and-market-analysis-to-2028-6rm58y3xakw4"></link>
<id>urn:uuid:11b2de2b-bb6a-e4d1-f843-bf2a1b5f3521</id>
<summary type="html"><![CDATA[Age-related macular degeneration (AMD) is an eye condition that is characterized by the gradual deterioration of the macula]]></summary>
<updated>2020-04-24T08:34:55+00:00</updated>
</entry>
<entry>
<title>Chronic Obstructive Pulmonary Disease: Global Drug Forecast and Market Analysis to 2028</title>
<link href="https://news.prfree.org/@kiyara/chronic-obstructive-pulmonary-disease-global-drug-forecast-and-market-analysis-to-2028-6rmybr3qxkb4"></link>
<id>urn:uuid:1d894faa-b897-98e0-715d-9d38773e69e1</id>
<summary type="html"><![CDATA[Chronic obstructive pulmonary disease (COPD) is a common, preventable, incurable, and treatable disease that is characterized by persistent respiratory symptoms and airflow limitation.]]></summary>
<updated>2020-04-24T08:13:48+00:00</updated>
</entry>
<entry>
<title>Global Coal Mining to 2023 &amp; the impact of COVID-19</title>
<link href="https://news.prfree.org/@kiyara/global-coal-mining-to-2023-the-impact-of-covid-19-3rm63nxeakeq"></link>
<id>urn:uuid:a3b364a1-7d89-dd44-4ec5-4ce6b776bbff</id>
<summary type="html"><![CDATA[We are Research "Global Coal Mining to 2023 & the impact of COVID-19" analyses impact of coronavirus on the global coal mining industry,]]></summary>
<updated>2020-04-24T07:55:12+00:00</updated>
</entry>
<entry>
<title>The Global Body Armor and Personal Protection Market-2020-2030</title>
<link href="https://news.prfree.org/@kiyara/the-global-body-armor-and-personal-protection-market-2020-2030-63mbx4njnmb7"></link>
<id>urn:uuid:9cb9adea-9919-edab-1981-52c241897378</id>
<summary type="html"><![CDATA[The Global Body Armor and Personal Protection Market 2020-2030 report provides the market size forecast and the projected Compound Annual Growth Rate (CAGR)]]></summary>
<updated>2020-04-24T07:35:55+00:00</updated>
</entry>
<entry>
<title>Global Payments: Competitor Profile</title>
<link href="https://news.prfree.org/@kiyara/global-payments-competitor-profile-qak74ayj7my3"></link>
<id>urn:uuid:a9324394-1b8f-da42-8518-d2772c3edebd</id>
<summary type="html"><![CDATA[Global Payments is a global merchant acquiring and payment processing company that connects merchants directly to all major and local card schemes and alternative payment methods through its end-to-end solutions.]]></summary>
<updated>2020-04-24T07:16:03+00:00</updated>
</entry>
<entry>
<title>Premature Labor (Tocolysis) - Pipeline Review, H1 2020</title>
<link href="https://news.prfree.org/@kiyara/premature-labor-tocolysis-pipeline-review-h1-2020-y7m8x77n4me8"></link>
<id>urn:uuid:e6c65d5c-ac70-f89c-d84a-41ef23fd6946</id>
<summary type="html"><![CDATA[Research latest Pharmaceutical and Healthcare disease pipeline guide Premature Labor (Tocolysis) - Pipeline Review, H1 2020,]]></summary>
<updated>2020-04-23T09:04:26+00:00</updated>
</entry>
<entry>
<title>Arterial Thrombosis - Pipeline Review, H1 2020</title>
<link href="https://news.prfree.org/@kiyara/arterial-thrombosis-pipeline-review-h1-2020-yrkdbjjxek5x"></link>
<id>urn:uuid:4349d09d-4cf9-dc32-1e3d-82a7e2493a07</id>
<summary type="html"><![CDATA[Research latest Pharmaceutical and Healthcare disease pipeline guide Arterial Thrombosis - Pipeline Review, H1 2020]]></summary>
<updated>2020-04-23T08:52:31+00:00</updated>
</entry>
<entry>
<title>Myocardial Infarction - Pipeline Review, H1 2020</title>
<link href="https://news.prfree.org/@kiyara/myocardial-infarction-pipeline-review-h1-2020-3bmnp64ddm6p"></link>
<id>urn:uuid:940c1cae-e42f-4607-c127-d323c47ab917</id>
<summary type="html"><![CDATA[Research latest Pharmaceutical and Healthcare disease pipeline guide Myocardial Infarction - Pipeline Review]]></summary>
<updated>2020-04-23T08:38:46+00:00</updated>
</entry>
<entry>
<title>Polycystic Ovarian Syndrome - Pipeline Review, H1 2020</title>
<link href="https://news.prfree.org/@kiyara/polycystic-ovarian-syndrome-pipeline-review-h1-2020-63mbx4ynbmb7"></link>
<id>urn:uuid:4e9fb76a-bea1-8f16-23c2-d34b3ed87fff</id>
<summary type="html"><![CDATA[Research latest Pharmaceutical and Healthcare disease pipeline guide Polycystic Ovarian Syndrome - Pipeline Review, H1 2020]]></summary>
<updated>2020-04-23T08:18:49+00:00</updated>
</entry>
<entry>
<title>Chemotherapy Induced Peripheral Neuropathy - Pipeline Review, H1 2020</title>
<link href="https://news.prfree.org/@kiyara/chemotherapy-induced-peripheral-neuropathy-pipeline-review-h1-2020-3rmwyaparmn4"></link>
<id>urn:uuid:78d19bf3-0efa-a7f0-7ccd-6cf0932a4637</id>
<summary type="html"><![CDATA[Research latest Pharmaceutical and Healthcare disease pipeline guide Chemotherapy Induced Peripheral Neuropathy - Pipeline Review]]></summary>
<updated>2020-04-23T07:59:59+00:00</updated>
</entry>
<entry>
<title>Chemotherapy Induced Anemia - Pipeline Review, H1 2020</title>
<link href="https://news.prfree.org/@kiyara/chemotherapy-induced-anemia-pipeline-review-h1-2020-63mbx4y78mb7"></link>
<id>urn:uuid:70882e32-56d9-4790-a08b-aff5e62aa15b</id>
<summary type="html"><![CDATA[Research latest Pharmaceutical and Healthcare disease pipeline guide Chemotherapy Induced Anemia - Pipeline Review, H1 2020]]></summary>
<updated>2020-04-22T12:17:56+00:00</updated>
</entry>
<entry>
<title>GlaxoSmithKline plc - Enterprise Tech Ecosystem Series</title>
<link href="https://news.prfree.org/@kiyara/glaxosmithkline-plc-enterprise-tech-ecosystem-series-p7keay764kwx"></link>
<id>urn:uuid:23b1c704-14a0-126e-b874-3ed94ed0f4bb</id>
<summary type="html"><![CDATA[Action Potential Venture Capital is the bioelectronic medicines venture arm of GSK. It is focused on investing in start-ups]]></summary>
<updated>2020-04-22T11:45:01+00:00</updated>
</entry>
<entry>
<title>Pay-TV and OTT Video Market Trends in Asia-Pacific</title>
<link href="https://news.prfree.org/@kiyara/pay-tv-and-ott-video-market-trends-in-asia-pacific-ypm4ejd4bk85"></link>
<id>urn:uuid:e0a997fe-0f05-afde-6d0d-9f86660b6359</id>
<summary type="html"><![CDATA[Pay-TV and OTT Video Market Trends in Asia-Pacific’, a new Telecom Insider Report by Researcher,]]></summary>
<updated>2020-04-22T11:28:18+00:00</updated>
</entry>
<entry>
<title>The Multi-Cloud Imperative: Opportunities and Challenges</title>
<link href="https://news.prfree.org/@kiyara/the-multi-cloud-imperative-opportunities-and-challenges-86kprejapkr4"></link>
<id>urn:uuid:2910e5f6-e04a-47ac-048a-2200d92b2137</id>
<summary type="html"><![CDATA[The Multi-Cloud Imperative: Opportunities and Challenges' a new Global Outlook Report by Researcher, provides an executive-level]]></summary>
<updated>2020-04-22T11:13:32+00:00</updated>
</entry>
<entry>
<title>New Ways with Bundles: From FMS to Convergence 2.0</title>
<link href="https://news.prfree.org/@kiyara/new-ways-with-bundles-from-fms-to-convergence-20-y7m8x7dyame8"></link>
<id>urn:uuid:40c3e96d-b4f1-3f2a-453a-0123b25205e1</id>
<summary type="html"><![CDATA[New Ways with Bundles: From FMS to Convergence 2.0, a new Global Outlook Report by Researcher,]]></summary>
<updated>2020-04-22T10:59:58+00:00</updated>
</entry>
<entry>
<title>Phillips 66: Enterprise Tech Ecosystem Series</title>
<link href="https://news.prfree.org/@kiyara/phillips-66-enterprise-tech-ecosystem-series-ypm4ejnrek85"></link>
<id>urn:uuid:f72c6757-160e-a98d-9d4e-a56be0efb07a</id>
<summary type="html"><![CDATA[Phillips 66 is incorporating analytics-based decisions to model various business processes efficiently]]></summary>
<updated>2020-04-21T14:04:27+00:00</updated>
</entry>
<entry>
<title>The Progressive Corporation: Enterprise Tech Ecosystem</title>
<link href="https://news.prfree.org/@kiyara/the-progressive-corporation-enterprise-tech-ecosystem-p7keay5jrkwx"></link>
<id>urn:uuid:c36cdac7-2c5a-e320-c03f-a5f84d46da46</id>
<summary type="html"><![CDATA[The Progressive Corporation is an insurance holding company. It offers a range of personal and commercial automobile insurance, specialty property-casualty insurance, and other related services.]]></summary>
<updated>2020-04-21T13:38:03+00:00</updated>
</entry>
<entry>
<title>Legal &amp; General: Enterprise Tech Ecosystem Series</title>
<link href="https://news.prfree.org/@kiyara/legal-general-enterprise-tech-ecosystem-series-jekr746x6mxr"></link>
<id>urn:uuid:8f7fb03a-948c-ce68-4a3b-f6ef0733c4e7</id>
<summary type="html"><![CDATA[Legal & General provides insurance, saving, and investment products.]]></summary>
<updated>2020-04-21T12:45:22+00:00</updated>
</entry>
<entry>
<title>Anheuser-Busch InBev NV/SA: Enterprise Tech Ecosystem Series</title>
<link href="https://news.prfree.org/@kiyara/anheuser-busch-inbev-nv-sa-enterprise-tech-ecosystem-series-63mbx4qjnmb7"></link>
<id>urn:uuid:1e364401-e50b-4546-83c5-5def0d65b13f</id>
<summary type="html"><![CDATA[AB InBev has established a robust infrastructure of in-house research and development (R&D) facilities, technology ventures, and incubators.]]></summary>
<updated>2020-04-21T12:21:42+00:00</updated>
</entry>
<entry>
<title>Smart Money Investing in the Technology Sector - Q4 2019</title>
<link href="https://news.prfree.org/@kiyara/smart-money-investing-in-the-technology-sector-q4-2019-b7kxb7jn7kry"></link>
<id>urn:uuid:55654cdf-4e5b-8d5f-100b-6225fcfd79f0</id>
<summary type="html"><![CDATA[The report provides detailed information and insights into Smart Money Investing in the Technology Sector]]></summary>
<updated>2020-04-21T11:49:55+00:00</updated>
</entry>
<entry>
<title>COVID-19 Impact on Telecom Infrastructure Equipment - Thematic research</title>
<link href="https://news.prfree.org/@kiyara/covid-19-impact-on-telecom-infrastructure-equipment-thematic-research-3rmwyab84mn4"></link>
<id>urn:uuid:b3953463-6506-622d-8bc0-cfbae3d44c45</id>
<summary type="html"><![CDATA[The COVID-19 outbreak is now travelling around the world, leaving a trail of destruction in its wake.]]></summary>
<updated>2020-04-20T08:58:58+00:00</updated>
</entry>
<entry>
<title>COVID-19 Impact on Publishing - Thematic research</title>
<link href="https://news.prfree.org/@kiyara/covid-19-impact-on-publishing-thematic-research-yrkdbj787k5x"></link>
<id>urn:uuid:bdb51cf3-974f-3df8-794a-bb59dd4df1c3</id>
<summary type="html"><![CDATA[The COVID-19 outbreak is now travelling around the world, leaving a trail of destruction in its wake.]]></summary>
<updated>2020-04-20T08:43:44+00:00</updated>
</entry>
<entry>
<title>COVID-19 Impact on Component Makers - Thematic research</title>
<link href="https://news.prfree.org/@kiyara/covid-19-impact-on-component-makers-thematic-research-eqmj7q4bdkr6"></link>
<id>urn:uuid:906a13bc-55a9-9e43-0b1e-9978fb37701a</id>
<summary type="html"><![CDATA[The COVID-19 outbreak is now travelling around the world, leaving a trail of destruction in its wake.]]></summary>
<updated>2020-04-20T08:27:46+00:00</updated>
</entry>
<entry>
<title>Coronavirus Disease (COVID-19): Epidemiology Analysis and Forecast - March 2020</title>
<link href="https://news.prfree.org/@kiyara/coronavirus-disease-covid-19-epidemiology-analysis-and-forecast-march-2020-6rm58yw8ykw4"></link>
<id>urn:uuid:c2904ddd-75ce-711f-097a-8e8080ea651f</id>
<summary type="html"><![CDATA[The report covers current epidemiology situation, forecast, and analysis of COVID-19 in March 2020, including forecast for key markets.]]></summary>
<updated>2020-04-20T08:14:18+00:00</updated>
</entry>
<entry>
<title>COVID-19: Analysis of the Emerging Disease Landscape - March 2020</title>
<link href="https://news.prfree.org/@kiyara/covid-19-analysis-of-the-emerging-disease-landscape-march-2020-qak74a544my3"></link>
<id>urn:uuid:6ee26e70-d242-acbf-5d21-99734f123b05</id>
<summary type="html"><![CDATA[The epidemiology of COVID-19 is rapidly evolving and a number of companies have begun to invest in this space.]]></summary>
<updated>2020-04-20T07:43:49+00:00</updated>
</entry>
<entry>
<title>Air France and the COVID-19 Virus: Case Study</title>
<link href="https://news.prfree.org/@kiyara/air-france-and-the-covid-19-virus-case-study-p7keayxr8kwx"></link>
<id>urn:uuid:c2ee551f-97d7-fd16-04bd-8526b5db0b25</id>
<summary type="html"><![CDATA[COVID-19, commonly referred to as the Coronavirus, is dominating headlines the world over.]]></summary>
<updated>2020-04-17T13:03:04+00:00</updated>
</entry>
<entry>
<title>Impact of COVID-19 on Destinations: Case Study</title>
<link href="https://news.prfree.org/@kiyara/impact-of-covid-19-on-destinations-case-study-86kprex53kr4"></link>
<id>urn:uuid:67cabac2-8c2c-d579-5a72-54dbfa014a68</id>
<summary type="html"><![CDATA[All Tourism sectors are experiencing mass disruption which is leading to a fight for survival and causing severe economic impacts.]]></summary>
<updated>2020-04-17T12:48:39+00:00</updated>
</entry>
<entry>
<title>Dunkin Brands Group Inc.: Enterprise Tech Ecosystem Series</title>
<link href="https://news.prfree.org/@kiyara/dunkin-brands-group-inc-enterprise-tech-ecosystem-series-n6ma4358xkad"></link>
<id>urn:uuid:b778aa43-80e2-0130-e0ac-f65aee547409</id>
<summary type="html"><![CDATA[Dunkin' Brands Group Inc (Dunkin) is a franchisor of quick-service restaurants.]]></summary>
<updated>2020-04-17T12:28:32+00:00</updated>
</entry>
<entry>
<title>COVID-19 Impact on the Payments Industry: China Forecast Snapshot</title>
<link href="https://news.prfree.org/@kiyara/covid-19-impact-on-the-payments-industry-china-forecast-snapshot-3bmnp63jxm6p"></link>
<id>urn:uuid:68c6ef19-dae6-3360-d444-9696ca006f8d</id>
<summary type="html"><![CDATA[The coronavirus (SARS-CoV-2) outbreak, dubbed COVID-19, is first and foremost a human tragedy, affecting millions of people globally.]]></summary>
<updated>2020-04-17T12:09:51+00:00</updated>
</entry>
<entry>
<title>Barclays: Enterprise Tech Ecosystem Series</title>
<link href="https://news.prfree.org/@kiyara/barclays-enterprise-tech-ecosystem-series-p7keayp7bkwx"></link>
<id>urn:uuid:6e0fc260-c5a8-4704-4be5-edd2e8ba57f8</id>
<summary type="html"><![CDATA[Barclays is a global financial services provider offering personal and business banking, wholesale and commercial banking,]]></summary>
<updated>2020-04-17T10:53:19+00:00</updated>
</entry>
<entry>
<title>Financial Services: Adapting to the Coronavirus (COVID-19) Outbreak</title>
<link href="https://news.prfree.org/@kiyara/financial-services-adapting-to-the-coronavirus-covid-19-outbreak-3bmnp6qj4m6p"></link>
<id>urn:uuid:f116c75d-79a1-6f32-cc38-17517503c582</id>
<summary type="html"><![CDATA[In the short term, the impact of COVID-19 on consumer financial services will be analogous to the global financial crisis of 2008-09,]]></summary>
<updated>2020-04-16T13:10:05+00:00</updated>
</entry>
<entry>
<title>Quantemplate: Tech Innovator Profile</title>
<link href="https://news.prfree.org/@kiyara/quantemplate-tech-innovator-profile-3rmwyaej4mn4"></link>
<id>urn:uuid:2aa3d8b5-c98c-7086-3aa0-ed31be3ec617</id>
<summary type="html"><![CDATA[Quantemplate is an insurtech company that offers a data management and analytics platform]]></summary>
<updated>2020-04-16T12:43:57+00:00</updated>
</entry>
<entry>
<title>Bambu: Tech Innovator Profile</title>
<link href="https://news.prfree.org/@kiyara/bambu-tech-innovator-profile-ypm4ejq56k85"></link>
<id>urn:uuid:ca51f737-7bb3-75d4-f305-0c5b7a6f8638</id>
<summary type="html"><![CDATA[Founded in 2016, Bambu is a robo-advisory technology provider for business-to-business (B2B) firms including private banks,]]></summary>
<updated>2020-04-16T12:21:30+00:00</updated>
</entry>
<entry>
<title>UBS Group: Enterprise Tech Ecosystem Series</title>
<link href="https://news.prfree.org/@kiyara/ubs-group-enterprise-tech-ecosystem-series-y7m8x7papme8"></link>
<id>urn:uuid:786736b5-146a-3d90-742e-109bc992826c</id>
<summary type="html"><![CDATA[UBS Group offers wealth management, banking, asset management, and investment banking solutions.]]></summary>
<updated>2020-04-16T12:03:51+00:00</updated>
</entry>
<entry>
<title>HNW Offshore Investment: Drivers and Motivations</title>
<link href="https://news.prfree.org/@kiyara/hnw-offshore-investment-drivers-and-motivations-6rmybr4rykb4"></link>
<id>urn:uuid:de1ad572-707c-b6cb-efe0-9c484b4f780d</id>
<summary type="html"><![CDATA[The proportion of HNW individuals who invest offshore has been on the rise despite the scandals that have shaken the industry. While the reasons are diverse and differ from country to country,]]></summary>
<updated>2020-04-16T11:39:22+00:00</updated>
</entry>
</feed>